Compare · IVF vs MDLN
IVF vs MDLN
Side-by-side comparison of INVO Fertility Inc. (IVF) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IVF and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 17679.9x IVF ($2.7M).
- MDLN has been more active in the news (7 items in the past 4 weeks vs 1 for IVF).
- MDLN has more recent analyst coverage (25 ratings vs 0 for IVF).
- Company
- INVO Fertility Inc.
- Medline Inc.
- Price
- $0.56+1.27%
- $35.95-1.74%
- Market cap
- $2.7M
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 1
- 7
- Recent ratings
- 0
- 25
Latest IVF
- Amendment: SEC Form SCHEDULE 13G/A filed by INVO Fertility Inc.
- INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
- SEC Form S-8 filed by INVO Fertility Inc.
- INVO Fertility Inc. filed SEC Form 8-K: Regulation FD Disclosure
- INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
- INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International
- INVO Fertility Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
- SEC Form 10-Q filed by INVO Fertility Inc.
- SEC Form 424B3 filed by INVO Fertility Inc.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M